Skip to content
Recall Observatory FDA recall evidence

Drug product

Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20.

D-0319-2019

October 29, 2018

Class II

Product summary

Firm
GE Healthcare Inc. Life Sciences
Event
Event 81691
Status
Terminated
Classification
Class II
Quantity
1092 cartons
Official record key
drug-enforcement:D-0319-2019

Official wording

Reason: Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.

Code information: Lot #: 14301544, Exp 21Sep21

Distribution pattern: TN

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    glass particles
  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    lack of sterility